The founding team at Prologue Medicines (from L-R): CEO Lovisa Afzelius, chief scientific officer Hozefa Bandukwala, and president Theonie Anastassiadis

Flag­ship com­mits $50M to new start­up that scours vi­ral pro­teins for new drugs

In the midst of the Covid-19 pan­dem­ic, while most sci­en­tists were busy plot­ting new ways to com­bat virus­es, one start­up qui­et­ly be­gan a coun­ter­in­tu­itive cam­paign …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.